Recoding May Limit Breast Cancer Reconstruction Options Recoding May Limit Breast Cancer Reconstruction Options
The federal government ' s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.KFF Health News
Source: Medscape Hematology-Oncology Headlines - May 31, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

An Introduction to Jupyter Notebooks
Hey, there! Explore the World of Jupyter Notebooks: Unleashing the Power of Interactive Coding Hey there! As an avid Python enthusiast and data analyst, I have always believed that the right tools can make a world of difference in our coding journeys. And that’s precisely where Jupyter Notebooks…#jupyternotebooks #ipythonnotebooks #jupyternotebook #latex #ctrlenter #pythonista
Source: Reuters: Health - May 23, 2023 Category: Consumer Health News Source Type: news

Using natural language processing to predict fatal drug overdose from autopsy narrative text: algorithm development and validation study - Tang LA, Korona-Bailey J, Zaras D, Roberts A, Mukhopadhyay S, Espy S, Walsh CG.
BACKGROUND: Fatal drug overdose surveillance informs prevention but is often delayed because of autopsy report processing and death certificate coding. Autopsy reports contain narrative text describing scene evidence and medical history (similar to prelimi...
Source: SafetyLit - May 22, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

An external validation of coding for childhood maltreatment in routinely collected primary and secondary care data - John A, McGregor J, Marchant A, DelPozo-Banos M, Farr I, Nurmatov U, Kemp A, Naughton A.
Validated methods of identifying childhood maltreatment (CM) in primary and secondary care data are needed. We aimed to create the first externally validated algorithm for identifying maltreatment using routinely collected healthcare data. Comprehensive co...
Source: SafetyLit - May 22, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Super Simple Way to Build Bitcoin Dashboard with ChatGPT
There is no doubt that, one of the most important phase of a Data Science project is Data Visualization. Creating impressive and live visuals, will give you and your project a head start. Of course, you can create a dashboard by coding from…#datavisualization #tableau #powerbi #googledatastudio #create #jupyternotebook #elsethenpycharm #pycharm #input #h1cryptocurrencylive
Source: Reuters: Health - May 20, 2023 Category: Consumer Health News Source Type: news

Bone flap infections after craniotomy: a review of 63 cases and the implications for definitions, classification and surveillance methodologies
Conclusion: Greater clarity on how to define BFI is required to enable better classification and the carrying out of appropriate surveillance. This will inform preventative strategies and more effective patient management.
Source: Current Awareness Service for Health (CASH) - May 16, 2023 Category: Consumer Health News Source Type: news

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer
Irregularities in the body's genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn’t clear. Could abnormalities in non-coding material also impact a person’s health, or even be linked to cancers as well?
Source: World Pharma News - May 15, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Android Studio gets a built-in coding bot
Android Studio, like so much of Google’s product portfolio, is getting its infusion of AI today at the company’s annual I/O developer conference. Android Studio Hedgehog, the upcoming version of Android Studio currently in the canary release channel, will be the first to add support for the here.,…#androidstudio #google #codey #googles #palm #studiobot #githubscopilot #amazon #codewhisperer #vscode
Source: Reuters: Health - May 10, 2023 Category: Consumer Health News Source Type: news

FDA accepts application for Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
Acceptance based on two phase III studies that demonstrated early and sustained vision improvement with Vabysmo, meeting primary endpoint of non-inferiority compared to afliberceptApplication was further supported by data showing Vabysmo achieved rapid and robust drying of retinal fluidIf approved, RVO would be the third indication for Vabysmo in addition to neovascular or ‘wet’ age-related macular degeneration (nAMD) and diabetic macular edema (DME)Vabysmo is currently approved in 60 countries to treat nAMD and DME, with nearly one million doses distributed globallyBasel, 9 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY...
Source: Roche Investor Update - May 9, 2023 Category: Pharmaceuticals Source Type: news

To Make a Real Difference in Health Care, AI Will Need to Learn Like We Do
Millions of people, many of whom have never thought much about computer science, are experimenting with generative AI models such as the eminently conversational ChatGPT and creative image generator DALL-E. While these products reflect less of a technological breakthrough than AI’s emergence into the public consciousness, the traction they have found is guiding massive investment streams—investment shaping how this technology will be applied for years to come. For those of us who have long been bullish on AI’s potential to transform society, especially in key areas such as health and medicine, recent mont...
Source: TIME: Health - May 3, 2023 Category: Consumer Health News Authors: Vijay Pande Tags: Uncategorized Innovation Technology TIME 2030 Source Type: news

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
HORSHAM, Pa., May 2, 2023 – Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. (CBMG) to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for the treatment of B-cell malignancies. These investigational CD20-directed autologous CAR-Ts have demonstrated promising overall and complete response rates in Phase 1 studies in patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL) in China, with the m...
Source: Johnson and Johnson - May 2, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

From AWS to Aave & Lens Protocol: Nader Dabit Explains Web 3 Social Media and Gasless Transactions
Today we are joined by the all around dev phenomenon Nader Dabit. Nader has become a household name across the developer community with his combination of to the point tutorials, live coding demos and interviews focused on modern web development, Web 3, AI, cloud computing and more. He’s always…#naderdabit #devrelations #aavelens #lensprotocol #lens
Source: Reuters: Health - May 2, 2023 Category: Consumer Health News Source Type: news

From AWS to Aave & Lens Protocol: Nader Dabit Explains Web 3 Social Media
Nader has become a household name across the developer community with his combination of to-the-point tutorials, live coding demos and interviews focused on modern web development, Web 3, AI, cloud computing and more. He’s always learning and experimenting in public. Nader is currently the…#devrelations #aavelens #lensprotocol #lens # #staderlabs #ethereum #lens3306building #polygon #4744aboutexecution
Source: Reuters: Health - May 2, 2023 Category: Consumer Health News Source Type: news

Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Gu érin-Unresponsive Non-Muscle-Invasive Bladder Cancer
CHICAGO, April 30, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from the open-label Phase 2 SunRISe-1 study evaluating the efficacy and safety of TAR-200 monotherapy (a novel investigational intravesical drug delivery system) and cetrelimab monotherapy (an investigational anti-PD-1 monoclonal antibody administered intravenously) in patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC), who are ineligible for, or decline, radical cystectomy. The study demonstrated that 72.7 percent of patients treated wit...
Source: Johnson and Johnson - April 30, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20